PRIORIX Israel - English - Ministry of Health

priorix

glaxo smith kline (israel) ltd - live attenuated measles virus; live attenuated mumps virus; live attenuated rubella virus - powder and solvent for solution for injection - live attenuated mumps virus 10^3.7 ccid50; live attenuated rubella virus 10^3.0 ccid50; live attenuated measles virus 10^3.0 ccid50 - rubella, combinations with mumps, live attenuated - rubella, combinations with mumps, live attenuated - priorix is indicated for active immunisation of children from the age of 9 months or older, adolescents and adults against measles, mumps and rubella.

Mevac-A NLT 6.50 Lg CCID 50 / 0.5mL Freeze-Dried Powder for Suspension for Injection SC Philippines - English - FDA (Food And Drug Administration)

mevac-a nlt 6.50 lg ccid 50 / 0.5ml freeze-dried powder for suspension for injection sc

vaxines trading inc - hepatitis a vaccine (live, attenuated) - freeze-dried powder for suspension for injection sc - nlt 6.50 lg ccid 50 / 0.5ml

Mevac-A NLT 6.50 Lg CCID 50 Vial Philippines - English - FDA (Food And Drug Administration)

mevac-a nlt 6.50 lg ccid 50 vial

n/a; importer: vaxines trading inc.; distributor: vaxines trading inc. - hepatitis a vaccine (live, attenuated) - vial - nlt 6.50 lg ccid 50

CSL HEPATITIS B IMMUNOGLOBULIN VF (human) 400IU injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

csl hepatitis b immunoglobulin vf (human) 400iu injection vial

csl behring australia pty ltd - hepatitis b immunoglobulin, quantity: 400 iu; human immunoglobulin g, quantity: 160 mg/ml - injection, solution - excipient ingredients: glycine; water for injections; human immunoglobulin a - hepatitis b immunoglobulin-vf is indicated for post-exposure prophylaxis in persons who did not receive prior vaccination, or whose prior vaccination regimen is incomplete, or when the hepatitis b antibody level is inadequate (<10iu/l). post-exposure prophylaxis should be considered following percutaneous or permucosal exposure to hbsag-positive or suspected hbsag-positive material, for example, by needle stick, oral ingestion or sexual exposure. hepatitis b immunoglobulin-vf is also indicated for prophylaxis in infants born to hbsag-positive mothers.

Hepatitis B Immunoglobulin-VF 100IU New Zealand - English - Medsafe (Medicines Safety Authority)

hepatitis b immunoglobulin-vf 100iu

csl behring (nz) ltd - hepatitis b immunoglobulin, human 160 mg/ml ((>= 98% )as human plasma proteins (exnz)) - solution for injection - 100 iu - active: hepatitis b immunoglobulin, human 160 mg/ml ((>= 98% )as human plasma proteins (exnz)) excipient: glycine water for injection - hepatitis b immunoglobulin-vf is indicated for post-exposure prophylaxis in persons who did not receive prior vaccination, or whose prior vaccination regimen is incomplete, or when the hepatitis b antibody level is inadequate (< 10 iu/l). post-exposure prophylaxis should be considered following percutaneous or permucosal exposure to hbsag-positive or suspected hbsag-positive material, for example, by needle stick, oral ingestion or sexual exposure. hepatitis b immunoglobulin-vf is also indicated for prophylaxis in infants born to hbsag-positive mothers.

Hepatitis B Immunoglobulin-VF 400IU New Zealand - English - Medsafe (Medicines Safety Authority)

hepatitis b immunoglobulin-vf 400iu

csl behring (nz) ltd - hepatitis b immunoglobulin, human 160 mg/ml (( >= 98%) as human plasma proteins (ex nz)) - solution for injection - 400 iu - active: hepatitis b immunoglobulin, human 160 mg/ml (( >= 98%) as human plasma proteins (ex nz)) excipient: glycine water for injection - hepatitis b immunoglobulin-vf is indicated for post-exposure prophylaxis in persons who did not receive prior vaccination, or whose prior vaccination regimen is incomplete, or when the hepatitis b antibody level is inadequate (< 10 iu/l). post-exposure prophylaxis should be considered following percutaneous or permucosal exposure to hbsag-positive or suspected hbsag-positive material, for example, by needle stick, oral ingestion or sexual exposure. hepatitis b immunoglobulin-vf is also indicated for prophylaxis in infants born to hbsag-positive mothers.

Livac-A NLT 6.5LgCCID50/0.5mL Vial Philippines - English - FDA (Food And Drug Administration)

livac-a nlt 6.5lgccid50/0.5ml vial

vaxines trading inc.; distributor: united laboratories, inc. - live attenuated hepatitis a vaccine - vial - nlt 6.5lgccid50/0.5ml

Hepatitis B Vaccine (rDNA) (Adult) Suspension For Injection Kenya - English - Pharmacy and Poisons Board

hepatitis b vaccine (rdna) (adult) suspension for injection

serum institute of india ltd. 212/2 hadapsar pune 411028 india - hepatitis b vaccine (rdna) (adult) - suspension for injection - each dose of 1 ml contains purified hepatitis b… - viral vaccines: hepatitisvaccines

Hepatitis B Vaccine (rDNA) (Paediatric) Suspension For Injection Kenya - English - Pharmacy and Poisons Board

hepatitis b vaccine (rdna) (paediatric) suspension for injection

serum institute of india ltd. 212/2 hadapsar pune 411028 india - hepatitis b vaccine (rdna) (paediatric) - suspension for injection - each dose of 0.5 ml contains purified hepatitis… - viral vaccines: hepatitisvaccines